James Desemone

441 total citations
12 papers, 348 citations indexed

About

James Desemone is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, James Desemone has authored 12 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 3 papers in Genetics. Recurrent topics in James Desemone's work include Diabetes Management and Research (4 papers), Diabetes and associated disorders (3 papers) and Pancreatic function and diabetes (3 papers). James Desemone is often cited by papers focused on Diabetes Management and Research (4 papers), Diabetes and associated disorders (3 papers) and Pancreatic function and diabetes (3 papers). James Desemone collaborates with scholars based in United States. James Desemone's co-authors include John P. Mordes, Aldo A. Rossini, Cesar C. Palerm, John Willis, B. Wayne Bequette, Daniel W. Lee, Matthew C. Leinung, Andrew G. Gianoukakis, Eugene S. Handler and John A. DiPreta and has published in prestigious journals such as Journal of the American Academy of Orthopaedic Surgeons, Diabetes Technology & Therapeutics and Endocrine Practice.

In The Last Decade

James Desemone

11 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Desemone United States 7 210 184 160 41 35 12 348
Norra Kwong United States 13 438 2.1× 287 1.6× 127 0.8× 18 0.4× 52 1.5× 15 635
S. Munkgaard Rasmussen Denmark 8 154 0.7× 136 0.7× 85 0.5× 13 0.3× 28 0.8× 13 375
Mustafa Tosur United States 11 200 1.0× 159 0.9× 201 1.3× 12 0.3× 18 0.5× 47 339
Barbara Jenko Bizjan Slovenia 10 142 0.7× 114 0.6× 90 0.6× 10 0.2× 14 0.4× 30 298
K. Sayama Japan 9 123 0.6× 140 0.8× 140 0.9× 111 2.7× 80 2.3× 14 411
Sybille Hanke Germany 9 249 1.2× 101 0.5× 182 1.1× 30 0.7× 18 0.5× 16 436
Iwona Pietrzak Poland 12 351 1.7× 331 1.8× 291 1.8× 14 0.3× 13 0.4× 44 578
M Iavicoli Italy 12 325 1.5× 121 0.7× 186 1.2× 49 1.2× 34 1.0× 23 431
Sunil Jain India 10 438 2.1× 330 1.8× 336 2.1× 92 2.2× 16 0.5× 26 654
Mozhgan Dorkhan Sweden 13 164 0.8× 53 0.3× 93 0.6× 17 0.4× 23 0.7× 22 326

Countries citing papers authored by James Desemone

Since Specialization
Citations

This map shows the geographic impact of James Desemone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Desemone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Desemone more than expected).

Fields of papers citing papers by James Desemone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Desemone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Desemone. The network helps show where James Desemone may publish in the future.

Co-authorship network of co-authors of James Desemone

This figure shows the co-authorship network connecting the top 25 collaborators of James Desemone. A scholar is included among the top collaborators of James Desemone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Desemone. James Desemone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
2.
Shabbir, Muhammad Asim, et al.. (2020). Is our initial evaluation of patients admitted for syncope guideline-directed and cost-effective?. European Heart Journal - Case Reports. 4(2). 1–4. 3 indexed citations
3.
4.
Waxman, Michael, James Desemone, John W. O’Kane, et al.. (2018). Hospitalized patients' and family members' preferences for real-time, transparent access to their hospital records.. PubMed. 24(1). e17–e23. 1 indexed citations
5.
Rosano, T G, et al.. (2015). Insulin Glargine and Insulin Aspart Overdose With Pharmacokinetic Analysis. AACE Clinical Case Reports. 2(2). e122–e128. 5 indexed citations
6.
Uhl, Richard L., Andrew J. Rosenbaum, John A. DiPreta, James Desemone, & Michael Mulligan. (2014). Diabetes Mellitus. Journal of the American Academy of Orthopaedic Surgeons. 22(3). 183–192. 31 indexed citations
7.
Palerm, Cesar C., John Willis, James Desemone, & B. Wayne Bequette. (2005). Hypoglycemia Prediction and Detection Using Optimal Estimation. Diabetes Technology & Therapeutics. 7(1). 3–14. 75 indexed citations
8.
Leinung, Matthew C., et al.. (2000). Comparison of Diabetes Care Provided by an Endocrinology Clinic and A Primary-Care Clinic. Endocrine Practice. 6(5). 361–366. 41 indexed citations
9.
Kitagawa, Yoshihiro, James Desemone, & John P. Mordes. (1993). Pancreas-specific venular labeling by Monastral blue B in the BB rat: modulation by prostaglandins and their inhibitors. Immunopharmacology. 25(3). 229–238. 2 indexed citations
10.
Desemone, James, Guido Majno, Isabelle Joris, et al.. (1990). Morphological and physiological characteristics of pancreas-specific venular permeability induced by monastral blue B. Experimental and Molecular Pathology. 52(1). 141–153. 6 indexed citations
11.
Majno, Guido, I Joris, Eugene S. Handler, et al.. (1987). A pancreatic venular defect in the BB/Wor rat.. PubMed. 128(2). 210–5. 32 indexed citations
12.
Mordes, John P., James Desemone, & Aldo A. Rossini. (1987). The BB rat. Diabetes/Metabolism Reviews. 3(3). 725–750. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026